Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Messonnier

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Journal of Public Health|August 4, 2022
Evaluation of non-continuous temperature monitoring practices for vaccine storage units: A Monte Carlo simulation studyAndrew J Leidner, Carla E Lee, Ashley Tippins, et al.
Advances in Health Economics and Health Services Research|September 24, 2014
Adolescent girls' preferences for HPV vaccines: a discrete choice experimentDerek S Brown, Christine Poulos, F Reed Johnson, et al.
Vaccine|February 23, 2016
Impact and cost-effectiveness of a second tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine dose to prevent pertussis in the United StatesHajime Kamiya, Bo-Hyun Cho, Mark L Messonnier, et al.
Archives of Pediatrics & Adolescent Medicine|December 8, 2010
Financial barriers to the adoption of combination vaccines by pediatriciansCourtney A Gidengil, M Maya Dutta-Linn, Mark L Messonnier, et al.
American Journal of Preventive Medicine|April 13, 1999
An ounce of prevention ... what are the returns? Second edition, 1999M L Messonnier, P S Corso, S M Teutsch, et al.
Pediatrics|May 29, 2013
Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: a decision analysisAndrew Terranella, Garrett R Beeler Asay, Mark L Messonnier, et al.
International Journal of Sports Medicine|April 2, 2003
Differences in lactate exchange and removal abilities in athletes specialised in different track running events (100 to 1500 m)C Bret, L Messonnier, J M Nouck Nouck, et al.
Filaria Journal|February 3, 2004
Willingness to pay for prevention and treatment of lymphatic filariasis in Leogane, HaitiRichard D Rheingans, Anne C Haddix, Mark L Messonnier, et al.
Pediatrics|July 4, 2013
Cost-effectiveness of using 2 vs 3 primary doses of 13-valent pneumococcal conjugate vaccineCharles Stoecker, Lee M Hampton, Ruth Link-Gelles, et al.
Vaccine|November 3, 2009
MCV vaccination in the presence of vaccine-associated Guillain-Barré Syndrome risk: a decision analysis approachBo-Hyun Cho, Thomas A Clark, Nancy E Messonnier, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Journal of Public Health|August 4, 2022
Evaluation of non-continuous temperature monitoring practices for vaccine storage units: A Monte Carlo simulation studyAndrew J Leidner, Carla E Lee, Ashley Tippins, et al.
Advances in Health Economics and Health Services Research|September 24, 2014
Adolescent girls' preferences for HPV vaccines: a discrete choice experimentDerek S Brown, Christine Poulos, F Reed Johnson, et al.
Vaccine|February 23, 2016
Impact and cost-effectiveness of a second tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine dose to prevent pertussis in the United StatesHajime Kamiya, Bo-Hyun Cho, Mark L Messonnier, et al.
Archives of Pediatrics & Adolescent Medicine|December 8, 2010
Financial barriers to the adoption of combination vaccines by pediatriciansCourtney A Gidengil, M Maya Dutta-Linn, Mark L Messonnier, et al.
American Journal of Preventive Medicine|April 13, 1999
An ounce of prevention ... what are the returns? Second edition, 1999M L Messonnier, P S Corso, S M Teutsch, et al.
Pediatrics|May 29, 2013
Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: a decision analysisAndrew Terranella, Garrett R Beeler Asay, Mark L Messonnier, et al.
International Journal of Sports Medicine|April 2, 2003
Differences in lactate exchange and removal abilities in athletes specialised in different track running events (100 to 1500 m)C Bret, L Messonnier, J M Nouck Nouck, et al.
Filaria Journal|February 3, 2004
Willingness to pay for prevention and treatment of lymphatic filariasis in Leogane, HaitiRichard D Rheingans, Anne C Haddix, Mark L Messonnier, et al.
Pediatrics|July 4, 2013
Cost-effectiveness of using 2 vs 3 primary doses of 13-valent pneumococcal conjugate vaccineCharles Stoecker, Lee M Hampton, Ruth Link-Gelles, et al.
Vaccine|November 3, 2009
MCV vaccination in the presence of vaccine-associated Guillain-Barré Syndrome risk: a decision analysis approachBo-Hyun Cho, Thomas A Clark, Nancy E Messonnier, et al.
Pageof 5